The network parameter at different distances. by Fei Wang (19534)

“…Distance increased the relative abundance of Actinobacteria, Acidobacteria, and Chloroflexi, but significantly decreased the relative abundance of Proteobacteria and Firmicutes. …”

Box plot of queens and males in the young colony (left) and old colony (right) A-B compares the queens and males distribution in the young and old colonies, respectively. by Moïse Pierre Exélis (21578515)

A Wettability Gradient Synergistic Bionic Wedge-Shaped Track for Ultrafast and Long-Distance Spontaneous Transport of Droplets by Xinghai Zhong (21450285)

“…To address the aforementioned challenges, we developed a bionic wedge-shaped track on the copper (Cu) substrate inspired by the cone-shaped thorn of cactus for liquid spontaneous transport. …”

A Wettability Gradient Synergistic Bionic Wedge-Shaped Track for Ultrafast and Long-Distance Spontaneous Transport of Droplets by Xinghai Zhong (21450285)

“…To address the aforementioned challenges, we developed a bionic wedge-shaped track on the copper (Cu) substrate inspired by the cone-shaped thorn of cactus for liquid spontaneous transport. …”

A Wettability Gradient Synergistic Bionic Wedge-Shaped Track for Ultrafast and Long-Distance Spontaneous Transport of Droplets by Xinghai Zhong (21450285)

“…To address the aforementioned challenges, we developed a bionic wedge-shaped track on the copper (Cu) substrate inspired by the cone-shaped thorn of cactus for liquid spontaneous transport. …”

A Wettability Gradient Synergistic Bionic Wedge-Shaped Track for Ultrafast and Long-Distance Spontaneous Transport of Droplets by Xinghai Zhong (21450285)

“…To address the aforementioned challenges, we developed a bionic wedge-shaped track on the copper (Cu) substrate inspired by the cone-shaped thorn of cactus for liquid spontaneous transport. …”

A Wettability Gradient Synergistic Bionic Wedge-Shaped Track for Ultrafast and Long-Distance Spontaneous Transport of Droplets by Xinghai Zhong (21450285)

“…To address the aforementioned challenges, we developed a bionic wedge-shaped track on the copper (Cu) substrate inspired by the cone-shaped thorn of cactus for liquid spontaneous transport. …”

A Wettability Gradient Synergistic Bionic Wedge-Shaped Track for Ultrafast and Long-Distance Spontaneous Transport of Droplets by Xinghai Zhong (21450285)

“…To address the aforementioned challenges, we developed a bionic wedge-shaped track on the copper (Cu) substrate inspired by the cone-shaped thorn of cactus for liquid spontaneous transport. …”

Schematic diagram of numerical simulation model. by Mengyun Li (7490870)

“…Finally, using the established prediction method, we calculated the limiting conditions for the existence of weak water-flushed zones in the X oil field test area. …”

The result of molecular dynamics simulation. by Ashraf Attia Mahmoud (21262201)

“…The docking research indicated that these mutations decreased the binding affinity for DNA, with R273C, R280G, G266E, and G105C displaying the most significant differences. …”

Result of the phenotypic analysis. by Ashraf Attia Mahmoud (21262201)

“…The docking research indicated that these mutations decreased the binding affinity for DNA, with R273C, R280G, G266E, and G105C displaying the most significant differences. …”

Type of Mutations. by Ashraf Attia Mahmoud (21262201)

“…The docking research indicated that these mutations decreased the binding affinity for DNA, with R273C, R280G, G266E, and G105C displaying the most significant differences. …”

S1 File - by Zsófia Tróznai (19923854)

“…Larger body height increased the likelihood of selection by about 12%, larger muscle mass by 12% to 25%, larger bone age by 350–400%, while larger percent body fat decreased selection chances by 7%. …”

Flowchart of the selection program. by Zsófia Tróznai (19923854)

“…Larger body height increased the likelihood of selection by about 12%, larger muscle mass by 12% to 25%, larger bone age by 350–400%, while larger percent body fat decreased selection chances by 7%. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Baseline analysis, nominal factors. by Hiroaki Yoshikawa (4615801)

“…Conversely, the occurrence of myasthenic crisis and current MG-ADL scores were lower in 2018. Regarding treatment, the utilization of tacrolimus, plasma exchange (PE), and intravenous immunoglobulin (IVIg) significantly increased between 2006 and 2018. …”